- Home
- CYTK vs NJR Comparison
CYTK vs NJR Comparison
Compare CYTK & NJR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- NJR
- Stock Information
- Founded
- CYTK 1997
- NJR 1922
- Country
- CYTK United States
- NJR United States
- Employees
- CYTK N/A
- NJR N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- NJR Oil/Gas Transmission
- Sector
- CYTK Health Care
- NJR Utilities
- Exchange
- CYTK Nasdaq
- NJR Nasdaq
- Market Cap
- CYTK 5.6B
- NJR 4.6B
- IPO Year
- CYTK 2004
- NJR N/A
- Fundamental
- Price
- CYTK $37.73
- NJR $46.14
- Analyst Decision
- CYTK Buy
- NJR Hold
- Analyst Count
- CYTK 14
- NJR 6
- Target Price
- CYTK $70.92
- NJR $51.33
- AVG Volume (30 Days)
- CYTK 1.4M
- NJR 626.2K
- Earning Date
- CYTK 08-07-2025
- NJR 08-04-2025
- Dividend Yield
- CYTK N/A
- NJR 3.91%
- EPS Growth
- CYTK N/A
- NJR 63.33
- EPS
- CYTK N/A
- NJR 4.14
- Revenue
- CYTK $19,218,000.00
- NJR $2,072,804,000.00
- Revenue This Year
- CYTK $27.08
- NJR $6.93
- Revenue Next Year
- CYTK $652.09
- NJR $2.86
- P/E Ratio
- CYTK N/A
- NJR $11.13
- Revenue Growth
- CYTK 412.21
- NJR 20.48
- 52 Week Low
- CYTK $29.31
- NJR $42.33
- 52 Week High
- CYTK $61.38
- NJR $51.95
- Technical
- Relative Strength Index (RSI)
- CYTK 55.97
- NJR 52.44
- Support Level
- CYTK $36.71
- NJR $45.75
- Resistance Level
- CYTK $38.54
- NJR $47.14
- Average True Range (ATR)
- CYTK 1.33
- NJR 0.70
- MACD
- CYTK -0.03
- NJR 0.05
- Stochastic Oscillator
- CYTK 61.38
- NJR 53.77
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About NJR NewJersey Resources Corporation
New Jersey Resources is an energy services holding company with regulated and nonregulated operations. Its regulated utility, New Jersey Natural Gas, delivers natural gas to nearly 600,000 customers in the state. NJR's nonregulated businesses include investments in commercial solar projects and several large midstream natural gas projects.